Literature DB >> 2910757

Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.

D S Levine1, B J Reid, R C Haggitt, C E Rubin, P S Rabinovitch.   

Abstract

Barrett's esophagus develops as a complication of chronic gastroesophageal reflux and predisposes patients to the development of dysplasia and adenocarcinoma of the esophagus. Because light microscopy of dysplasia in Barrett's esophagus shows diminished or absent mucus, we used transmission electron microscopy to compare cytoplasmic organelles required for mucus production in dysplastic and nondysplastic esophageal columnar epithelium. These observations of the rough endoplasmic reticulum, Golgi apparatus, and secretory granules were correlated with histologic interpretations and flow cytometric measurements of abnormalities of DNA content. Ultrastructural abnormalities included depletion and alteration of organelles required for mucus biosynthesis. These abnormalities often were accompanied by cells with markedly distended rough endoplasmic reticulum and massive accumulation of cytoplasmic glycogen aggregates. All 9 patients who had Barrett's dysplasia with or without early adenocarcinoma had ultrastructural abnormalities, as did 3 of 8 patients whose biopsy histology was indefinite for dysplasia. Abnormalities measured by flow cytometry correlated well with the presence of these ultrastructural aberrations. All 9 patients with Barrett's dysplasia with or without early adenocarcinoma had abnormalities observed by electron microscopy and aneuploidy or increased G2/tetraploid fractions measured by flow cytometry. Two of the 3 patients whose biopsies were indefinite for dysplasia and who had ultrastructural abnormalities also had aneuploidy or increased G2/tetraploid fractions. Neither ultrastructural nor flow cytometric abnormalities were found in the remaining 5 patients whose biopsies were indefinite for dysplasia, in 19 of 22 patients with Barrett's specialized metaplasia, or in any of the 7 patients with gastroesophageal reflux disease without Barrett's specialized metaplasia. Two of the 22 patients with Barrett's specialized metaplasia had distended rough endoplasmic reticulum in rare cells, and one other had an aneuploid cell population. We conclude that neoplastic progression in Barrett's esophagus is associated with abnormalities of cytoplasmic organelles required for mucus production. With few exceptions, these ultrastructural aberrations correspond to the presence of dysplasia or of aneuploidy or increased G2/tetraploid fractions. Electron microscopy and flow cytometery detect abnormalities associated with the development of dysplasia and cancer in Barrett's esophagus that may be biologically significant.

Entities:  

Mesh:

Year:  1989        PMID: 2910757     DOI: 10.1016/s0016-5085(89)91559-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

Review 2.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management.

Authors:  Brian J Reid; Rumen Kostadinov; Carlo C Maley
Journal:  Clin Cancer Res       Date:  2011-04-15       Impact factor: 12.531

4.  Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.

Authors:  M Miros; P Kerlin; N Walker
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

5.  Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae.

Authors:  Michael T Barrett; Ka Yee Yeung; Walter L Ruzzo; Li Hsu; Patricia L Blount; Robert Sullivan; Helmut Zarbl; Jeffrey Delrow; Peter S Rabinovitch; Brian J Reid
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

Review 6.  Evolution and progression of Barrett's oesophagus to oesophageal cancer.

Authors:  Sarah Killcoyne; Rebecca C Fitzgerald
Journal:  Nat Rev Cancer       Date:  2021-09-20       Impact factor: 60.716

Review 7.  Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.

Authors:  Brian J Reid; Xiaohong Li; Patricia C Galipeau; Thomas L Vaughan
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

Review 8.  The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Gianmarco Contino; Thomas L Vaughan; David Whiteman; Rebecca C Fitzgerald
Journal:  Gastroenterology       Date:  2017-07-14       Impact factor: 22.682

Review 9.  Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.

Authors:  Hiroshi Nakagawa; Kelly Whelan; John P Lynch
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-11-12       Impact factor: 2.695

10.  Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Derek J Nancarrow; Andrew D Clouston; B Mark Smithers; David C Gotley; Paul A Drew; David I Watson; Sonika Tyagi; Nicholas K Hayward; David C Whiteman
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.